Sherman Mark Andrew's Form 4 filing
Dolby Laboratories, Inc. (DLB) · filed Dec 19, 2023
- Accession no.
- 0001209191-23-059261
- Filed
- Dec 19, 2023
- Trade date
- Dec 15-19, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $906.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sherman Mark AndrewCIK 0001256708 | Officer (EVP, Gen. Counsel & Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2023 | Class A Common Stock | AGrant or awardAcquired | +16,726 | $0.00 | $0 | 73,456 | Direct | |
| Dec 15, 2023 | Class A Common Stock | MOption exerciseAcquired | +5,738 | $0.00F3 | $0 | 79,194 | Direct | |
| Dec 15, 2023 | Class A Common Stock | FTax withholdingDisposed | −8,713 | $88.60 | −$771,971.8 | 70,481 | Direct | |
| Dec 18, 2023 | Class A Common Stock | FTax withholdingDisposed | −1,637 | $87.49 | −$143,221.13 | 68,844 | Direct | |
| Dec 18, 2023 | Class A Common Stock | SSaleDisposed | −8,856 | $86.19F7 | −$763,298.64 | 59,988 | Direct | |
| Dec 19, 2023 | Class A Common Stock | SSaleDisposed | −1,663 | $86.01F8 | −$143,034.63 | 58,325 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2023 | Class A Common Stock | AGrant or awardAcquired | +8,363 | $0.00 | $0 | 8,363 | Direct | |
| Dec 15, 2023 | Class A Common Stock | AGrant or awardAcquired | +29,316 | $0.00 | $0 | 29,316 | Direct | |
| Dec 15, 2023 | Class A Common Stock | MOption exerciseDisposed | −5,738 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Each performance-based restricted stock unit (PSU) represented a contingent right to receive, upon vesting, one share of Issuer Class A common stock.
Referenced by the price of 1 transaction in Table I.
- F7
The shares were sold in multiple transactions at prices ranging from $85.86 to $86.78, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
- F8
The shares were sold in multiple transactions at prices ranging from $85.89 to $86.138, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.
Remarks
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 22, 2023 which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.